Literature DB >> 31620853

Functional and anatomical imaging in pediatric oncology: which is best for which tumors.

Stephan D Voss1.   

Abstract

Functional imaging techniques are playing an increasingly important role in the management of pediatric cancer. Technological advances have pushed the development of hybrid imaging techniques, including positron emission tomography (PET)/CT, PET/MR and single-photon emission computed tomography (SPECT)/CT. Together with an increasing need to identify surrogate biomarkers for response to novel therapies, the use of functional imaging techniques, which had been reserved primarily for lymphoma patients, is now being recognized as standard of care for the management of many other pediatric solid tumors. The purpose of this review is to summarize recent data describing the use of functional and metabolic imaging strategies for the staging and response assessment of common pediatric solid tumors, and to offer some guidance as to which techniques are most appropriate for which tumor types.

Entities:  

Keywords:  Children; Ewing sarcoma; Functional imaging; Metabolic imaging; Metaiodobenzylguanidine; Neuroblastoma; Positron emission tomography computed tomography; Rhabdomyosarcoma; Single-photon emission computed tomography; Solid tumor

Year:  2019        PMID: 31620853     DOI: 10.1007/s00247-019-04489-z

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  49 in total

1.  Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry.

Authors:  Joanna Begent; Neil J Sebire; Gill Levitt; Penelope Brock; Kathy Pritchard Jones; Peter Ell; Isky Gordon; John Anderson
Journal:  Eur J Cancer       Date:  2010-11-10       Impact factor: 9.162

2.  PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.

Authors:  Brett M Paterson; Peter Roselt; Delphine Denoyer; Carleen Cullinane; David Binns; Wayne Noonan; Charmaine M Jeffery; Roger I Price; Jonathan M White; Rodney J Hicks; Paul S Donnelly
Journal:  Dalton Trans       Date:  2013-11-07       Impact factor: 4.390

3.  The FDA Warning on Anesthesia Drugs.

Authors:  Steven Ganzberg
Journal:  Anesth Prog       Date:  2017

Review 4.  Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

Authors:  Julie R Park; Rochelle Bagatell; Susan L Cohn; Andrew D Pearson; Judith G Villablanca; Frank Berthold; Susan Burchill; Ariane Boubaker; Kieran McHugh; Jed G Nuchtern; Wendy B London; Nita L Seibel; O Wolf Lindwasser; John M Maris; Penelope Brock; Gudrun Schleiermacher; Ruth Ladenstein; Katherine K Matthay; Dominique Valteau-Couanet
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

5.  MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.

Authors:  Steven G DuBois; Rajen Mody; Arlene Naranjo; Collin Van Ryn; Douglas Russ; Derek Oldridge; Susan Kreissman; David L Baker; Marguerite Parisi; Barry L Shulkin; Harrison Bai; Sharon J Diskin; Vandana Batra; John M Maris; Julie R Park; Katherine K Matthay; Gregory Yanik
Journal:  Pediatr Blood Cancer       Date:  2017-04-06       Impact factor: 3.167

6.  Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.

Authors:  Michelle Phillips; Carl Allen; Paul Gerson; Kenneth McClain
Journal:  Pediatr Blood Cancer       Date:  2009-01       Impact factor: 3.167

7.  Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.

Authors:  Lars M Wagner; Nathalie Kremer; Michael J Gelfand; Susan E Sharp; Brian K Turpin; Rajaram Nagarajan; Gregory M Tiao; Joseph G Pressey; Julie Yin; Roshni Dasgupta
Journal:  Cancer       Date:  2016-08-26       Impact factor: 6.860

8.  Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

Authors:  Ruth Ladenstein; Bieke Lambert; Ulrike Pötschger; Maria-Rita Castellani; Valerie Lewington; Zvi Bar-Sever; Aurore Oudoux; Anna Śliwińska; Katerina Taborska; Lorenzo Biassoni; Gregory A Yanik; Arlene Naranjo; Marguerite T Parisi; Barry L Shulkin; Helen Nadel; Michael J Gelfand; Katherine K Matthay; Julie R Park; Susan G Kreissman; Dominique Valteau-Couanet; Ariane Boubaker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-23       Impact factor: 9.236

Review 9.  Neuroblastoma and nephroblastoma: a radiological review.

Authors:  Maureen Dumba; Noorulhuda Jawad; Kieran McHugh
Journal:  Cancer Imaging       Date:  2015-04-08       Impact factor: 3.909

Review 10.  Whole-body MRI in paediatric oncology.

Authors:  Rutger A J Nievelstein; Annemieke S Littooij
Journal:  Radiol Med       Date:  2015-12-02       Impact factor: 3.469

View more
  1 in total

1.  GEIS-SEHOP clinical practice guidelines for the treatment of rhabdomyosarcoma.

Authors:  S Gallego; D Bernabeu; M Garrido-Pontnou; G Guillen; N Hindi; A Juan-Ribelles; C Márquez; C Mata; J Orcajo; G Ramírez; M Ramos; C Romagosa; D Ruano; P Rubio; R Vergés; C Valverde
Journal:  Clin Transl Oncol       Date:  2021-07-01       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.